| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.16 | 0.006 |